Global Market Study on Human Insulin: With more people getting diagnosed with Diabetes, the market to be on the expansion spree

May 2022| PMR1924A| Persistence Market Research

Report Highlights

Human Insulin Market Analysis 2022-2028

A recent market study published by Persistence Market Research (PMR) on the Human Insulin Market including global industry analysis for 2014-2021 & opportunity assessment for 2022-2028, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the market, growth prospects are obtained with utmost precision.

Human Insulin Market: Segmentation

The global Human Insulin Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Type

  • Modern Human Insulin
  • Fast-acting
  • Long-acting
  • Premix
  • Traditional Human Insulin
  • Long-acting
  • Short-acting
  • Fast-acting
  • Premix

Type of Diabetes

  • Diabetes Type 1
  • Diabetes Type 2

Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa (MEA)

Key Questions Answered in Report

The research study offers inclusive insights about the growth of the market in the most comprehensive manner. Key insights offered in the report answer some of the most salient questions that assist stakeholders in gauging all the emerging possibilities.

  • What are the key trends that are continuously shaping market growth?
  • Which are the prominent regions that offer plentiful opportunities for players in the market?
  • How has the outbreak of COVID-19 affected the market and what would the trend be like during the forecast period?
  • What are the differential strategies adopted by key players to hold a significant share in the human insulin industry?

Research Methodology

A unique and promising research methodology forms the base of the market report for the forecast period. This report has been prepared after comprehensive analysis of market events, and riveting insights have been compiled meticulously.

The research methodology is a two-step process comprising primary and secondary research. Key stakeholders, including suppliers, service providers, and experts of several designations, including executive vice presidents, directors, technical advisors, GM marketing professionals, and sales professionals have been interviewed. Secondary sources referred to obtain information include investor presentations of manufacturers, World Bank, IMF, and other credible sources.

The research report includes a competitive landscape that provides a dashboard view of the key competitors operating in the market. Some of the market players included in this section are Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Biocon, Pfizer Inc, Wockhardt, and Julpha, among others.

  • Table 1 : Market snapshot: Human insulin market, 2022 and 2028
  • Table 2 : Drivers for human insulin market: Impact analysis
  • Table 3 : Restraints for human insulin market: Impact analysis
  • Table 4 : Global human insulin market size, by region, 2014 – 2021 (USD million)
  • Table 5 : Global human insulin market size, by region, 2022 – 2028 (USD million)
  • Table 6 : Global human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 7 : Global human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 8 : Global traditional human insulin market size, by region, 2014 – 2021 (USD million)
  • Table 9 : Global traditional human insulin market size, by region, 2022 – 2028 (USD million)
  • Table 10 : Global modern human insulin market size, by region, 2014 – 2021 (USD million)
  • Table 11 : Global modern human insulin market size, by region, 2022 – 2028 (USD million)
  • Table 12 : Global short-acting human insulin market size, by region, 2014 – 2021 (USD million)
  • Table 13 : Global short-acting human insulin market size, by region, 2022 – 2028 (USD million)
  • Table 14 : Global intermediate-acting human insulin market size, by region, 2014 – 2021 (USD million)
  • Table 15 : Global intermediate-acting human insulin market size, by region, 2022 – 2028 (USD million)
  • Table 16 : Global premixed human insulin market size, by region, 2014 – 2021 (USD million)
  • Table 17 : Global premixed human insulin market size, by region, 2022 – 2028 (USD million)
  • Table 18 : Global rapid-acting human insulin market size, by region, 2014 – 2021 (USD million)
  • Table 19 : Global rapid-acting human insulin market size, by region, 2022 – 2028 (USD million)
  • Table 20 : Global long-acting human insulin market size, by region, 2014 – 2021 (USD million)
  • Table 21 : Global long-acting human insulin market size, by region, 2022 – 2028 (USD million)
  • Table 22 : Global type 1 diabetes human insulin market size, by region, 2014 – 2021 (USD million)
  • Table 23 : Global type 1 diabetes human insulin market size, by region, 2022 – 2028 (USD million)
  • Table 24 : Global type 2 diabetes human insulin market size, by region, 2014 – 2021 (USD million)
  • Table 25 : Global type 2 diabetes human insulin market size, by region, 2022 – 2028 (USD million)
  • Table 26 : Global traditional human insulin market size, by brand, 2014 – 2021 (USD million)
  • Table 27 : Global traditional human insulin market size, by brand, 2022 – 2028 (USD million)
  • Table 28 : Global modern human insulin market size, by brand, 2014 – 2021 (USD million)
  • Table 29 : Global modern human insulin market size, by brand, 2022 – 2028 (USD million)
  • Table 30 : The North American human insulin market size, by country, 2014 – 2021 (USD million)
  • Table 31 : The North American human insulin market size, by country, 2022 – 2028 (USD million)
  • Table 32 : The U.S. human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 33 : The U.S. human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 34 : The U.S. traditional human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 35 : The U.S. traditional human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 36 : The U.S. modern human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 37 : The U.S. modern human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 38 : The Canadian human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 39 : The Canadian human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 40 : The Canadian traditional human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 41 : The Canadian traditional human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 42 : The Canadian modern human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 43 : The Canadian modern human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 44 : The European human insulin market size, by country, 2014 – 2021 (USD million)
  • Table 45 : The European human insulin market size, by country, 2022 – 2028 (USD million)
  • Table 46 : The German human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 47 : The German human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 48 : The German traditional human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 49 : The German traditional human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 50 : The German modern human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 51 : The German modern human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 52 : The French human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 53 : The French human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 54 : The French traditional human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 55 : The French traditional human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 56 : The French modern human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 57 : The French modern human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 58 : The U.K. human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 59 : The U.K. human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 60 : The U.K. traditional human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 61 : The U.K. traditional human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 62 : The U.K. modern human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 63 : The U.K. modern human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 64 : The Asia Pacific human insulin market size, by country, 2014 – 2021 (USD million)
  • Table 65 : The Asia Pacific human insulin market size, by country, 2022 – 2028 (USD million)
  • Table 66 : The Japanese human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 67 : The Japanese human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 68 : The Japanese traditional human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 69 : The Japanese traditional human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 70 : The Japanese modern human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 71 : The Japanese modern human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 72 : The Chinese human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 73 : The Chinese human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 74 : The Chinese traditional human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 75 : The Chinese traditional human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 76 : The Chinese modern human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 77 : The Chinese modern human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 78 : The Indian human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 79 : The Indian human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 80 : The Indian traditional human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 81 : The Indian traditional human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 82 : The Indian modern human insulin market size, by type, 2014 – 2021 (USD million)
  • Table 83 : The Indian modern human insulin market size, by type, 2022 – 2028 (USD million)
  • Table 84 : Major pipeline drugs for diabetes treatment
  • Table 85 : Major product segments of Novo Nordisk A/S
  • Table 86 : Major product segments of Eli Lilly and Company
  • Table 87 : Major product categories of Sanofi
  • Table 88 : Major product categories of Biocon
  • Table 89 : Major product categories of Tonghua Dongbao Pharmaceutical Co., Ltd.
  • Table 90 : Major product categories of Adocia
  • Table 91 : Major product categories of Wockhardt
  • Table 92 : Major product categories of Julphar
  • Table 93 : Major product categories of Merck & Co., Inc.
  • Table 94 : Major product categories of Pfizer, Inc.
  • Table 95 : Major product categories of Bristol-Myers Squibb Company
  • Table 96 : Major product categories of GlaxoSmithKline Plc
  • Table 97 : Major product categories of Oramed Pharmaceuticals, Inc.
  • Figure 1 : Human insulin market: Porter’s five forces analysis: By Disease Indication
  • Figure 2 : Major types of human insulin
  • Figure 3 : Major types of insulin delivery devices
  • Figure 4 : Number of people with diabetes mellitus (20 – 79 years) in major countries, 2010 and 2030 (million)
  • Figure 5 : Prevalence of overweight and obese males aged 30 years and above, 2022 and 2021 (%)
  • Figure 6 : Prevalence of overweight and obese females aged 30 years and above, 2022 and 2021 (%)
  • Figure 7 : Global human insulin market share, by region, by value, 2022
  • Figure 8 : Global human insulin market share, by type, by value, 2022
  • Figure 9 : Global traditional human insulin market share, by region, by value, 2022
  • Figure 10 : Global modern human insulin market share, by region, by value, 2022
  • Figure 11 : Global short-acting human insulin market share, by region, by value, 2022
  • Figure 12 : Global intermediate-acting human insulin market share, by region, by value, 2022
  • Figure 13 : Global premixed human insulin market share, by region, by value, 2022
  • Figure 14 : Global rapid-acting human insulin market share, by region, by value, 2022
  • Figure 15 : Global long-acting human insulin market share, by region, by value, 2022
  • Figure 16 : Global type 1 diabetes human insulin market share, by region, by value, 2022
  • Figure 17 : Global type 2 diabetes human insulin market share, by region, by value, 2022
  • Figure 18 : Global traditional human insulin market share, by brand, by value, 2022
  • Figure 19 : Global modern human insulin market share, by brand, by value, 2022
  • Figure 20 : The North American human insulin market share, by country, by value, 2022
  • Figure 21 : The U.S. human insulin market share, by type, by value, 2022
  • Figure 22 : The U.S. traditional human insulin market share, by type, by value, 2022
  • Figure 23 : The U.S. modern human insulin market share, by type, by value, 2022
  • Figure 24 : The Canadian human insulin market share, by type, by value, 2022
  • Figure 25 : The Canadian traditional human insulin market share, by type, by value, 2022
  • Figure 26 : The Canadian modern human insulin market share, by type, by value, 2022
  • Figure 27 : The European human insulin market share, by country, by value, 2022
  • Figure 28 : The German human insulin market share, by type, by value, 2022
  • Figure 29 : The German traditional human insulin market share, by type, by value, 2022
  • Figure 30 : The German modern human insulin market share, by type, by value, 2022
  • Figure 31 : The French human insulin market share, by type, by value, 2022
  • Figure 32 : The French traditional human insulin market share, by type, by value, 2022
  • Figure 33 : The French modern human insulin market share, by type, by value, 2022
  • Figure 34 : The U.K. human insulin market share, by type, by value, 2022
  • Figure 35 : The U.K. traditional human insulin market share, by type, by value, 2022
  • Figure 36 : The U.K. modern human insulin market share, by type, by value, 2022
  • Figure 37 : The Asia Pacific human insulin market share, by country, by value, 2022
  • Figure 38 : The Japanese human insulin market share, by type, by value, 2022
  • Figure 39 : The Japanese traditional human insulin market share, by type, by value, 2022
  • Figure 40 : The Japanese modern human insulin market share, by type, by value, 2022
  • Figure 41 : The Chinese human insulin market share, by type, by value, 2022
  • Figure 42 : The Chinese traditional human insulin market share, by type, by value, 2022
  • Figure 43 : The Chinese modern human insulin market share, by type, by value, 2022
  • Figure 44 : The Indian human insulin market share, by type, by value, 2022
  • Figure 45 : The Indian traditional human insulin market share, by type, by value, 2022
  • Figure 46 : The Indian modern human insulin market share, by type, by value, 2022
  • Figure 47 : Competitive benchmarking of human insulin manufacturing companies
  • Figure 48 : Novo Nordisk’s net sales and net profit, 2022 – 2028 (USD million)
  • Figure 49 : Eli Lilly and Company’s revenue and net income, 2022 – 2028 (USD million)
  • Figure 50 : Sanofi’s net sales and net income, 2022 – 2028 (USD million)
  • Figure 51 : Biocon’s revenue and profit, 2012 – 2022 (USD million)
  • Figure 52 : Tonghua Dongbao Pharmaceutical Co., Ltd.’s total revenue and net income, 2022 – 2028 (USD million)
  • Figure 53 : Wockhardt’s revenue and net income, 2022 – 2028 (USD million)
  • Figure 54 : Julphar’s sales and profit, 2022 – 2028 (USD million)
  • Figure 55 : Merck & Co., Inc.’s sales and net income, 2022 – 2028 (USD million)
  • Figure 56 : Pfizer, Inc.’s revenue and net income, 2022 – 2028 (USD million)
  • Figure 57 : Bristol-Myers Squibb Company’s total revenue and net earnings, 2022 – 2028 (USD million)
  • Figure 58 : GlaxoSmithKline Plc’s turnover and profit, 2022 – 2028 (USD million)

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Persistence Market Research
Price: $4900

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Share This Report